$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Oct 13, 2025)
$774.37M
Market Cap
-
P/E Ratio
-1.21
EPS
$12.51
52 Week High
$1.64
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Iovance Biotherapeutics, Inc. is a pioneering clinical-stage biotechnology company based in San Carlos, California, dedicated to advancing cancer immunotherapy through innovative cell therapy solutions. The company's proprietary tumor-infiltrating lymphocyte (TIL) therapy aims to leverage and enhance the patient’s immune response to combat various cancer types, with a current focus on melanoma and cervical cancer. With a robust pipeline and a commitment to scientific excellence, Iovance is positioned to address significant unmet medical needs in oncology, making it a compelling investment opportunity in the rapidly evolving field of cancer treatment.